-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 23, with the roar of construction machines, the Hefei production base project of Haisen Biotechnology officially started construction
in Feidong County, Hefei City.
in Feidong County, Hefei City.
In recent years, Hefei has accelerated the construction of a high-quality industrial system, of which the biomedical industry is one of
the strategic emerging industries that Hefei focuses on cultivating and developing.
According to the "14th Five-Year Plan for the Development of Biomedical Industry in Hefei", by 2025, the output value of the city's biomedical industry will exceed 100 billion yuan
.
the strategic emerging industries that Hefei focuses on cultivating and developing.
According to the "14th Five-Year Plan for the Development of Biomedical Industry in Hefei", by 2025, the output value of the city's biomedical industry will exceed 100 billion yuan
.
Haisen Biotech is an innovative pharmaceutical company
focusing on chronic diseases and age-related diseases.
The project is located in the core area of the new city in the east of Feidong County, Hefei City, with an area of 25 acres in the first phase and an investment of 190 million yuan, including sub-packaging workshop, quality inspection laboratory, raw material and finished product warehouse, comprehensive building and supporting facilities
.
The project construction period is 14 months, and the process verification and trial operation will be completed by the end of 2024, and it is expected to be officially put into production
in 2025.
focusing on chronic diseases and age-related diseases.
The project is located in the core area of the new city in the east of Feidong County, Hefei City, with an area of 25 acres in the first phase and an investment of 190 million yuan, including sub-packaging workshop, quality inspection laboratory, raw material and finished product warehouse, comprehensive building and supporting facilities
.
The project construction period is 14 months, and the process verification and trial operation will be completed by the end of 2024, and it is expected to be officially put into production
in 2025.
Jiang Xin, general manager of Hefei Industry and Investment Group, chairman and general manager of Hefei Industry and Investment Group, said that Hefei Industry and Investment Group, as one of the important starting points for Hefei to play a leading role in state-owned assets and serve the development of emerging industries, through the methods of "fund + base" and "investment + investment", together with Feidong County and Kangqiao Capital to jointly incubate Haisen Biotechnology to become the industrial foundation of Hefei biomedicine, and drive the industrial landing
with capital investment.
In the future, we hope that all parties can have more cooperation and continue to promote the high-quality development
of Hefei's local industry.
with capital investment.
In the future, we hope that all parties can have more cooperation and continue to promote the high-quality development
of Hefei's local industry.
Yao Fei, Secretary of the Feidong County Party Committee, said in his speech that Feidong actively integrates into Hefei's industrial division of labor, vigorously develops the biomedical industry, and the biomedical industry has become an important force in Feidong's economy, with the scale exceeding the 10 billion mark
.
Feidong will make every effort to ensure the service and promote the early completion and production of the project, providing important support
for Hefei's biomedical sector to move up to the next level.
.
Feidong will make every effort to ensure the service and promote the early completion and production of the project, providing important support
for Hefei's biomedical sector to move up to the next level.
Xia Shaofei, CEO of Hesen Biotechnology, said that Hefei's good policies and business environment and gradually improving the biomedical industry chain have given Hisen Biotech the confidence
to continue to deepen its development in Hefei.
Through the whole industry and global layout, Haisen Biotech will connect the upstream and downstream industrial chains, build innovative medical and health enterprises, and help the development of
Anhui biomedical industry.
(End)
to continue to deepen its development in Hefei.
Through the whole industry and global layout, Haisen Biotech will connect the upstream and downstream industrial chains, build innovative medical and health enterprises, and help the development of
Anhui biomedical industry.
(End)
